ESC Premium Access

A global view: the rationale for aggresive LDL lowering

Congress Presentation

About the speaker

Professor Steven E Nissen

Cleveland Clinic Hospital, Cleveland (United States of America)
14 presentations
0 follower

3 more presentations in this session

Cholesterol metabolism and the role of PCSK9

Speaker: Professor S. Nicholls (Melbourne, AU)


Show me the data: clinical efficacy, safety and indications of PCSK9 inhibition

Speaker: Professor J. Jukema (Leiden, NL)


Are there effects of PCSK9 inhibitors beyond cholesterol lowering?

Speaker: Professor B. Cariou (Nantes, FR)


Access the full session

PCSK9 inhibition - cholesterol reduction and beyond

Speakers: Professor S. Nissen, Professor S. Nicholls, Professor J. Jukema, Professor B. Cariou

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb